Brain transcriptome perturbations in the Hfe -/- mouse model of genetic iron loading

Brain Research

Volumn 1448, Issue , 2012, Pages 144-152

  Johnstone, Daniel ^a,b,c   Graham, Ross M ^d,e,f   Trinder, Debbie ^d,e   Delima, Roheeth D ^d,e   Riveros, Carlos ^a,b   Olynyk, John K ^d,e,g,h   Scott, Rodney J ^a,b,i   Moscato, Pablo ^a,b   Milward, Elizabeth A ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^e UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^f CURTIN UNIVERSITY   (Australia)

^g CURTIN UNIVERSITY   (Australia)

^h FREMANTLE HOSPITAL   (Australia)

ⁱ JOHN HUNTER HOSPITAL   (Australia)

Author keywords

Hemochromatosis; HFE; Iron; Microarray; Mouse model

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; EARLY GROWTH RESPONSE FACTOR; HFE PROTEIN; IRON; LIPOFUSCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN FOS; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; GENE DISRUPTION; GENETIC TRANSCRIPTION; HEMOCHROMATOSIS; IRON INTAKE; IRON METABOLISM; IRON STORAGE; MALE; MICROARRAY ANALYSIS; MOUSE; NERVE CELL PLASTICITY; NEURONAL CEROID LIPOFUSCINOSIS; NEUROTRANSMISSION; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BRAIN CHEMISTRY; DIETARY SUPPLEMENTS; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; IRON; IRON OVERLOAD; IRON, DIETARY; LIVER; MALE; MEMBRANE PROTEINS; MEMORY; MICE; MICE, KNOCKOUT; MICROARRAY ANALYSIS; MOVEMENT DISORDERS; NEURONAL PLASTICITY; NONHEME IRON PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REGULATORY ELEMENTS, TRANSCRIPTIONAL; RNA; SYNAPTIC TRANSMISSION; TRANSCRIPTOME;

ANIMALIA; MUS;

EID: 84858701477     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.02.006     Document Type: Article

References (80)

1. Allen, K.J., Gurrin, L.C., Constantine, C.C., Osborne, N.J., Delatycki, M.B., Nicoll, A.J., McLaren, C.E., Bahlo, M., Nisselle, A.E., Vulpe, C.D., Anderson, G.J., Southey, M.C., Giles, G.G., English, D.R., Hopper, J.L., Olynyk, J.K., Powell, L.W., Gertig, D.M., 2008. Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. Med. 358, 221-230.
2. Andrews, N.C., 1999. Disorders of iron metabolism. N. Engl. J. Med. 341, 1986-1995.
3. Ayonrinde, O.T., Milward, E.A., Chua, A.C., Trinder, D., Olynyk, J.K., 2008. Clinical perspectives on hereditary hemochromatosis. Crit. Rev. Clin. Lab. Sci. 45, 451-484.
4. Bartzokis, G., Lu, P.H., Tishler, T.A., Peters, D.G., Kosenko, A., Barrall, K.A., Finn, J.P., Villablanca, P., Laub, G., Altshuler, L.L., Geschwind, D.H., Mintz, J., Neely, E., Connor, J.R., 2010. Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men. J. Alzheimers Dis. 20, 333-341.
5. Bastin, J.M., Jones, M., O'Callaghan, C.A., Schimanski, L., Mason, D.Y., Townsend, A.R., 1998. Kupffer cell staining by an HFE-specific monoclonal antibody: implications for hereditary haemochromatosis. Br. J. Haematol. 103, 931-941.
6. Bender, R., Lange, S., 2001. Adjusting for multiple testing - when and how? J. Clin. Epidemiol. 54, 343-349.
7. Benjamini, Y., Hochberg, Y., 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B Methodol. 57, 289-300.
8. Berg, D., Hoggenmuller, U., Hofmann, E., Fischer, R., Kraus, M., Scheurlen, M., Becker, G., 2000. The basal ganglia in haemochromatosis. Neuroradiology 42, 9-13.
9. Berretta, R., Moscato, P., 2010. Cancer biomarker discovery: the entropic hallmark. PLoS One 5, e12262.
10. Berretta, R., Costa, W., Moscato, P., 2008. Combinatorial optimization methods for finding genetic signatures from gene expression datasets. In: Keith, J. (Ed.), Bioinformatics. Methods in Molecular Biology. Humana Press, pp. 363-377 (Vol.).
11. Beutler, E., Felitti, V.J., Koziol, J.A., Ho, N.J., Gelbart, T., 2002. Penetrance of 845G to A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet 359, 211-218.
12. Bondy, C.A., Cheng, C.M., 2004. Signaling by insulin-like growth factor 1 in brain. Eur. J. Pharmacol. 490, 25-31.
13. Bravo, R., 1986. Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp. Cell Res. 163, 287-293.
14. Bray, N.J., Buckland, P.R., Williams, N.M., Williams, H.J., Norton, N., Owen, M.J., O'Donovan, M.C., 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am. J. Hum. Genet. 73, 152-161.
15. Brissot, P., Moirand, R., Jouanolle, A.M., Guyader, D., Le Gall, J.Y., Deugnier, Y., David, V., 1999. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J. Hepatol. 30, 588-593.
16. Burn, J., Chinnery, P.F., 2006. Neuroferritinopathy. Semin. Pediatr. Neurol. 13, 176-181.
17. Camaschella, C., 2005. Understanding iron homeostasis through genetic analysis of hemochromatosis and related disorders. Blood 106, 3710-3717.
18. Celis, J.E., Madsen, P., 1986. Increased nuclear cyclin/PCNA antigen staining of non S-phase transformed human amnion cells engaged in nucleotide excision DNA repair. FEBS Lett. 209, 277-283.
19. Cheah, J.H., Kim, S.F., Hester, L.D., Clancy, K.W., Patterson III, S.E., Papadopoulos, V., Snyder, S.H., 2006. NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1. Neuron 51, 431-440.
20. Cheng, D., Hoogenraad, C.C., Rush, J., Ramm, E., Schlager, M.A., Duong, D.M., Xu, P., Wijayawardana, S.R., Hanfelt, J., Nakagawa, T., Sheng, M., Peng, J., 2006. Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol. Cell. Proteomics 5, 1158-1170.
21. Chua, A.C., Herbison, C.E., Drake, S.F., Graham, R.M., Olynyk, J.K., Trinder, D., 2008. The role of Hfe in transferrin-bound iron uptake by hepatocytes. Hepatology 47, 1737-1744.
22. Connor, J.R., Milward, E.A., Moalem, S., Sampietro, M., Boyer, P., Percy, M.E., Vergani, C., Scott, R.J., Chorney, M., 2001. Is hemochromatosis a risk factor for Alzheimer's disease? J. Alzheimers Dis. 3, 471-477.
23. Cotta, C., Sloper, C., Moscato, P., 2004. Evolutionary search of thresholds for robust feature set selection: application to the analysis of microarray data. In: Raidl, G.R., Cagnoni, S., Branke, J., Corne, D.W., Drechsler, R., Jin, Y., Johnson, C.G., Machado, P., Marchiori, E., Rothlauf, F., Smith, G.D., Squillero, G. (Eds.), Applications of Evolutionary Computing. Lecture Notes in Computer Science. Springer, Berlin/Heidelberg, pp. 21-30 (Vol.).
24. Cutler, P., 1994. Iron overload and psychiatric illness. Can. J. Psychiatry 39, 8-11.
25. Demarquay, G., Setiey, A., Morel, Y., Trepo, C., Chazot, G., Broussolle, E., 2000. Clinical report of three patients with hereditary hemochromatosis and movement disorders. Mov. Disord. 15, 1204-1209.
26. Ellervik, C., Birgens, H., Tybjaerg-Hansen, A., Nordestgaard, B.G., 2007. Hemochromatosis genotypes and risk of 31 disease endpoints: meta-analyses including 66,000 cases and 226,000 controls. Hepatology 46, 1071-1080.
27. Fleming, R.E., Holden, C.C., Tomatsu, S., Waheed, A., Brunt, E.M., Britton, R.S., Bacon, B.R., Roopenian, D.C., Sly, W.S., 2001. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 98, 2707-2711.
28. Gao, J., Chen, J., Kramer, M., Tsukamoto, H., Zhang, A.S., Enns, C.A., 2009. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 9, 217-227.
29. Golub, M.S., Germann, S.L., Araiza, R.S., Reader, J.R., Griffey, S.M., Lloyd, K.C., 2005. Movement disorders in the Hfe knockout mouse. Nutr. Neurosci. 8, 239-244.
30. Gomez Ravetti, M., Rosso, O.A., Berretta, R., Moscato, P., 2010. Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease. PLoS One 5, e10153.
31. Goodall, E.F., Greenway, M.J., van Marion, I., Carroll, C.B., Hardiman, O., Morrison, K.E., 2005. Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS. Neurology 65, 934-937.
32. Gregory, A., Polster, B.J., Hayflick, S.J., 2009. Clinical and genetic delineation of neurodegeneration with brain iron accumulation. J. Med. Genet. 46, 73-80.
33. Hall II, E.C., Lee, S.Y., Mairuae, N., Simmons, Z., Connor, J.R., 2011. Expression of the HFE allelic variant H63D in SH-SY5Y cells affects tau phosphorylation at serine residues. Neurobiol. Aging 32, 1409-1419.
34. Hanninen, M.M., Haapasalo, J., Haapasalo, H., Fleming, R.E., Britton, R.S., Bacon, B.R., Parkkila, S., 2009. Expression of iron-related genes in human brain and brain tumors. BMC Neurosci. 10, 36.
35. Harvey, R.J., Summerfield, J.A., Fox, N.C., 1997. Dementia associated with haemochromatosis. A report of two cases. Eur. J. Neurol. 4, 318-322.
36. He, X., Lu, X., Hu, J., Xi, J., Zhou, D., Shang, H., Liu, L., Zhou, H., Yan, B., Yu, L., Hu, F., Liu, Z., He, L., Yao, X., Xu, Y., 2011. H63D polymorphism in the hemochromatosis gene is associated with sporadic amyotrophic lateral sclerosis in China. Eur. J. Neurol. 18, 359-361.
37. Honda, K., Casadesus, G., Petersen, R.B., Perry, G., Smith, M.A., 2004. Oxidative stress and redox-active iron in Alzheimer's disease. Ann. N. Y. Acad. Sci. 1012, 179-182.
38. Johnstone, D., Milward, E.A., 2010a. Molecular genetic approaches to understanding the roles and regulation of iron in brain health and disease. J. Neurochem. 113, 1387-1402.
39. Johnstone, D., Milward, E.A., 2010b. Genome-wide microarray analysis of brain gene expression in mice on a short-term high iron diet. Neurochem. Int. 56, 856-863.
40. Kaldor, I., 1954. Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron. Aust. J. Exp. Biol. Med. Sci. 32, 795-799.
41. Kelman, Z., 1997. PCNA: structure, functions and interactions. Oncogene 14, 629-640.
42. Knutson, M.D., Levy, J.E., Andrews, N.C., Wessling-Resnick, M., 2001. Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice. J. Nutr. 131, 1459-1464.
43. Kurz, T., Terman, A., Gustafsson, B., Brunk, U.T., 2008. Lysosomes in iron metabolism, ageing and apoptosis. Histochem. Cell Biol. 129, 389-406.
44. Lee, D.W., Andersen, J.K., 2010. Iron elevations in the aging Parkinsonian brain: a consequence of impaired iron homeostasis? J. Neurochem. 112, 332-339.
45. Lee, Y.S., Silva, A.J., 2009. The molecular and cellular biology of enhanced cognition. Nat. Rev. Neurosci. 10, 126-140.
46. Lee, S.Y., Patton, S.M., Henderson, R.J., Connor, J.R., 2007. Consequences of expressing mutants of the hemochromatosis gene (HFE) into a human neuronal cell line lacking endogenous HFE. FASEB J. 21, 564-576.
47. Lisman, J., Schulman, H., Cline, H., 2002. The molecular basis of CaMKII function in synaptic and behavioural memory. Nat. Rev. Neurosci. 3, 175-190.
48. Lopes, J.P., Blurton-Jones, M., Yamasaki, T.R., Agostinho, P., LaFerla, F.M., 2009. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology. J. Alzheimers Dis. 16, 541-549.
49. Mamiya, T., Yamada, K., Miyamoto, Y., Konig, N., Watanabe, Y., Noda, Y., Nabeshima, T., 2003. Neuronal mechanism of nociceptin-induced modulation of learning and memory: involvement of N-methyl-D-aspartate receptors. Mol. Psychiatry 8, 752-765.
50. Manabe, T., Noda, Y., Mamiya, T., Katagiri, H., Houtani, T., Nishi, M., Noda, T., Takahashi, T., Sugimoto, T., Nabeshima, T., Takeshima, H., 1998. Facilitation of long-term potentiation and memory in mice lacking nociceptin receptors. Nature 394, 577-581.
51. McLaren, G.D., McLaren, C.E., Adams, P.C., Barton, J.C., Reboussin, D.M., Gordeuk, V.R., Acton, R.T., Harris, E.L., Speechley, M.R., Sholinsky, P., Dawkins, F.W., Snively, B.M., Vogt, T.M., Eckfeldt, J.H., 2008. Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can. J. Gastroenterol. 22, 923-930.
52. Mitchell, R.M., Lee, S.Y., Simmons, Z., Connor, J.R., 2011. HFE polymorphisms affect cellular glutamate regulation. Neurobiol. Aging 32, 1114-1123.
53. Moldovan, G.L., Pfander, B., Jentsch, S., 2007. PCNA, the maestro of the replication fork. Cell 129, 665-679.
54. Moos, T., Morgan, E.H., 2004. The metabolism of neuronal iron and its pathogenic role in neurological disease: review. Ann. N. Y. Acad. Sci. 1012, 14-26.
55. Morey, J.S., Ryan, J.C., Van Dolah, F.M., 2006. Microarray validation: factors influencing correlation between oligonucleotide microarrays and real-time PCR. Biol. Proced. Online 8, 175-193.
56. Muckenthaler, M.U., Galy, B., Hentze, M.W., 2008. Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197-213.
57. Nandar, W., Connor, J.R., 2011. HFE gene variants affect iron in the brain. J. Nutr. 141, 729S-739S.
58. Naryzhny, S.N., 2008. Proliferating cell nuclear antigen: a proteomics view. Cell. Mol. Life Sci. 65, 3789-3808.
59. Nielsen, J.E., Jensen, L.N., Krabbe, K., 1995. Hereditary haemochromatosis: a case of iron accumulation in the basal ganglia associated with a parkinsonian syndrome. J. Neurol. Neurosurg. Psychiatry 59, 318-321.
60. Noda, Y., Mamiya, T., Manabe, T., Nishi, M., Takeshima, H., Nabeshima, T., 2000. Role of nociceptin systems in learning and memory. Peptides 21, 1063-1069.
61. Olynyk, J.K., Cullen,D.J., Aquilia, S., Rossi, E., Summerville, L., Powell, L.W., 1999. Apopulation-based study of the clinical expression of the hemochromatosis gene. N. Engl. J. Med. 341, 718-724.
62. Pietrangelo, A., 2006. Hereditary hemochromatosis. Annu. Rev. Nutr. 26, 251-270.
63. Puglielli, L., 2008. Aging of the brain, neurotrophin signaling, and Alzheimer's disease: is IGF1-R the common culprit? Neurobiol. Aging 29, 795-811.
64. Reeves, P.G., Nielsen, F.H., Fahey Jr., G.C., 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951.
65. Riveros, C., Mellor, D., Gandhi, K.S., McKay, F.C., Cox, M.B., Berretta, R., Vaezpour, S.Y., Inostroza-Ponta, M., Broadley, S.A., Heard, R.N., Vucic, S., Stewart, G.J., Williams, D.W., Scott, R.J., Lechner-Scott, J., Booth, D.R., Moscato, P., 2010. A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis. PLoS One 5, e14176.
66. Rocha de Paula, M., Gomez Ravetti, M., Berretta, R., Moscato, P., 2011. Differences in abundances of cell-signalling proteins in blood reveal novel biomarkers for early detection of clinical Alzheimer's disease. PLoS One 6, e17481.
67. Rothman, K.J., 1990. No adjustments are needed for multiple comparisons. Epidemiology 1, 43-46.
68. Russo, N., Edwards, M., Andrews, T., O'Brien, M., Bhatia, K.P., 2004. Hereditary haemochromatosis is unlikely to cause movement disorders-a critical review. J. Neurol. 251, 849-852.
69. Rutgers, M.P., Pielen, A., Gille, M., 2007. Chronic cerebellar ataxia and hereditary hemochromatosis: causal or coincidental association? J. Neurol. 254, 1296-1297.
70. Schmidt, P.J., Toran, P.T., Giannetti, A.M., Bjorkman, P.J., Andrews, N.C., 2008. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab. 7, 205-214.
71. Schuler, V., Luscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., Schmutz, M., Heid, J., Gentry, C., Urban, L., Fox, A., Spooren, W., Jaton, A.L., Vigouret, J., Pozza, M., Kelly, P.H., Mosbacher, J., Froestl, W., Kaslin, E., Korn, R., Bischoff, S., Kaupmann, K., van der Putten, H., Bettler, B., 2001. Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1)). Neuron 31, 47-58.
72. Siintola, E., Lehesjoki, A.E., Mole, S.E., 2006. Molecular genetics of the NCLs - status and perspectives. Biochim. Biophys. Acta 1762, 857-864.
73. Sutedja, N.A., Sinke, R.J., Van Vught, P.W., Van der Linden, M.W., Wokke, J.H., Van Duijn, C.M., Njajou, O.T., Van der Schouw, Y.T., Veldink, J.H., Van den Berg, L.H., 2007. The association between H63D mutations in HFE and amyotrophic lateral sclerosis in a Dutch population. Arch. Neurol. 64, 63-67.
74. Sweet, R.A., Devlin, B., Pollock, B.G., Sukonick, D.L., Kastango, K.B., Bacanu, S.A., Chowdari, K.V., DeKosky, S.T., Ferrell, R.E., 2005. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol. Psychiatry 10, 1026-1036.
75. Terman, A., Brunk, U.T., 2004. Lipofuscin. Int. J. Biochem. Cell Biol. 36, 1400-1404.
76. Trinder, D., Olynyk, J.K., Sly, W.S., Morgan, E.H., 2002. Iron uptake from plasma transferrin by the duodenum is impaired in the Hfe knockout mouse. Proc. Natl. Acad. Sci. U. S. A. 99, 5622-5626.
77. Wang, X.S., Lee, S., Simmons, Z., Boyer, P., Scott, K., Liu, W., Connor, J., 2004. Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J. Neurol. Sci. 227, 27-33.
78. Whitlock, E.P., Garlitz, B.A., Harris, E.L., Beil, T.L., Smith, P.R., 2006. Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force. Ann. Intern. Med. 145, 209-223.
79. Zeng, X.R., Jiang, Y., Zhang, S.J., Hao, H., Lee, M.Y., 1994. DNA polymerase delta is involved in the cellular response to UV damage in human cells. J. Biol. Chem. 269, 13748-13751.
80. Zhou, X.Y., Tomatsu, S., Fleming, R.E., Parkkila, S., Waheed, A., Jiang, J., Fei, Y., Brunt, E.M., Ruddy, D.A., Prass, C.E., Schatzman, R.C., O'Neill, R., Britton, R.S., Bacon, B.R., Sly, W.S., 1998. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc. Natl. Acad. Sci. U. S. A. 95, 2492-2497.